Large-scale testing (Phase 3)Study completedNCT01262924
What this trial is testing
Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine
Who this might be right for
Diphteria, Tetanus and Pertussis
GlaxoSmithKline 116